ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Infectious Disease

Top Infectious Disease Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
EMILY YURBERG M.D.

Infectious Disease

15,968

$494K

256
246 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 50%

$31
Average prescription price

Avg: $285

REZA CHOWDHURY MD

Infectious Disease

12,743

$924K

253
136 are 65+

25%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 50%

$73
Average prescription price

Avg: $285

ALICIA HERMOGENES MD

Infectious Disease

11,212

$1.36M

326
170 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

26%
patients receiving schedule three controlled substances

Avg: 4%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 50%

$121
Average prescription price

Avg: $285

RIZWANULLAH HAMEED M.D.

Infectious Disease

10,420

$743K

479
397 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 50%

$71
Average prescription price

Avg: $285

ALLAN SANTIAGO MD

Infectious Disease

8,946

$441K

341
283 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 50%

$49
Average prescription price

Avg: $285

ABDUL-HAKI ISSAH M.D.

Infectious Disease

7,959

$542K

218
174 are 65+

11%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 50%

$68
Average prescription price

Avg: $285

JOTIR RAMNARINE MD

Infectious Disease

7,890

$829K

318
254 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

5%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 50%

$105
Average prescription price

Avg: $285

ADEL SULAIMAN MD

Infectious Disease

7,653

$2.72M

245
45 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 50%

$355
Average prescription price

Avg: $285

PETER ALPERT MD

Infectious Disease

7,576

$3.36M

224
65 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 50%

$444
Average prescription price

Avg: $285

SARMISTHA BHATTACHARYA MD

Infectious Disease

6,820

$546K

349
298 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 50%

$80
Average prescription price

Avg: $285

MARIA SANTANA MD

Infectious Disease

6,726

$2.05M

193
103 are 65+

9%
patients receiving schedule two controlled substances

Avg: 5%

14%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 50%

$305
Average prescription price

Avg: $285

MURRAY JONAS MD

Infectious Disease

6,438

$546K

357
283 are 65+

6%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 50%

$85
Average prescription price

Avg: $285

FRANK SCAFURI D.O.

Infectious Disease

6,228

$799K

604
448 are 65+

3%
patients receiving schedule two controlled substances

Avg: 5%

3%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 50%

$128
Average prescription price

Avg: $285

DAVID GOLDBERG M.D.

Infectious Disease

6,114

$467K

411
379 are 65+

4%
patients receiving schedule two controlled substances

Avg: 5%

4%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 50%

$76
Average prescription price

Avg: $285

MITCHELL BRODEY MD

Infectious Disease

5,936

$903K

304
239 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

6%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 50%

$152
Average prescription price

Avg: $285

ROBERTO CORALES DO

Infectious Disease

5,751

$2.1M

159
19 are 65+

21%
patients receiving schedule two controlled substances

Avg: 5%

29%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 50%

$366
Average prescription price

Avg: $285

JOSEPH MCGOWAN MD

Infectious Disease

5,614

$3.1M

140
20 are 65+

13%
patients receiving schedule two controlled substances

Avg: 5%

11%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

67%
prescriptions for brand name drugs

Avg: 50%

$552
Average prescription price

Avg: $285

ANDRE BRUTUS

Infectious Disease

5,523

$2.56M

171
54 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 50%

$464
Average prescription price

Avg: $285

KALPANA RAMDAS MD

Infectious Disease

5,435

$341K

156
143 are 65+

8%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 50%

$63
Average prescription price

Avg: $285

MICHAEL MULLEN MD

Infectious Disease

5,429

$2.27M

171
76 are 65+

16%
patients receiving schedule two controlled substances

Avg: 5%

12%
patients receiving schedule three controlled substances

Avg: 4%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

58%
prescriptions for brand name drugs

Avg: 50%

$417
Average prescription price

Avg: $285

ADEDAYO ADEDEJI M.D.

Infectious Disease

5,421

$1.4M

91
15 are 65+

27%
patients receiving schedule two controlled substances

Avg: 5%

34%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 50%

$259
Average prescription price

Avg: $285

DEBRA BERG MD

Infectious Disease

5,285

$754

125
121 are 65+

0%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 4%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 50%

$0
Average prescription price

Avg: $285

LEONARD BERKOWITZ MD

Infectious Disease

5,120

$2.58M

173
47 are 65+

10%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 50%

$503
Average prescription price

Avg: $285

JOSE BONOAN M.D.

Infectious Disease

5,077

$411K

209
180 are 65+

7%
patients receiving schedule two controlled substances

Avg: 5%

8%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 50%

$81
Average prescription price

Avg: $285

AHMED RABBAT M.D.

Infectious Disease

4,990

$281K

275
259 are 65+

21%
patients receiving schedule two controlled substances

Avg: 5%

0%
patients receiving schedule three controlled substances

Avg: 4%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 50%

$56
Average prescription price

Avg: $285

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank